Major provincial projects accelerated: Jianshi Medical Wuxi base was opened

WUXI, Nov.
13, 2022 /PRNewswire/ -- On November 13, the Wuxi base of HealthCare in Wuxi Mashan National Life Science Park was officially opened, with Wuxi Mayor Zhao Jianjun, academicians Ge Junbo and Teng Gaojun of the Chinese Academy of Sciences, Wang Yue, executive director of the China Drug Regulatory Research Association, Wang Xin, chairman and CEO of HealthCare Technology Group, and Wuxi city leaders Zhou Wendong and Chen Shoubin attending the opening ceremony
.

Before the opening ceremony, HealthCare and Wuxi Binhu District jointly held the "2022 Yangtze River Delta High-end Medical Device Innovation and Development Forum"
.
Two academicians, Ge Junbo and Teng Gaojun, delivered keynote speeches, and many experts, doctors and investors gathered together to conduct in-depth discussions
on the topic of "integration of medicine and engineering, leading innovation".

The foundation stone
of the Wuxi base was laid in November 2020.
The project is listed as a major industrial project in Jiangsu Province in 2021 and 2022, with a total investment of 5 billion yuan and an area of about 203 mu
.
The first phase of the project, with an investment of 1.
5 billion yuan, including two R&D and production buildings and an innovation center building, took only 22 months from the foundation laying and starting construction to trial production
.

Among them, the R&D and production building began trial operation in September this year, mainly engaged in the research and development and production of high-value medical devices such as minimally invasive surgery, vascular intervention (including neurointervention, cardiac intervention and peripheral intervention), and is planned to be officially put into operation in the first half of 2023, and is expected to form an output value of more than 10 billion yuan after 3 to 5 years of operation
.

The Innovation Center building is equipped with advanced minimally invasive surgery laboratory and interventional surgery laboratory, which provides cutting-edge clinical training for domestic medical professionals by highly restoring the environment of the hospital's operating room, and promotes the transition
between high-end medical devices from "made" to "usable".
According to HealthFit, the new center can meet the training needs of minimally invasive surgery, various types of vascular intervention and heart valve replacement, and the annual training capacity is expected to exceed 7,000 people
.

Sun Haidong, Secretary of Wuxi Binhu District Party Committee, delivered a speech
at the opening ceremony.
He mentioned: "The official opening of Fitness Wuxi is not only a milestone for the company's future development, but also an important industrial landmark
in the field of life and health in Binhu.
"

"The Wuxi base is an important support
for the development strategy of Fitness.
We will rely on the Wuxi base to accelerate innovation and create product differentiation, and at the same time use Wuxi's production and quality management capabilities to export healthy 'Made in China'
to emerging markets around the world in the future.
" In addition, we will also introduce international cutting-edge products and carry out localization and mass production in Wuxi, so as to promote the popularization
of new technologies and new products in China.
Wang Xin, chairman and CEO of HealthFit Medical Technology Group, said
.

According to HealthFit, its self-developed peripheral interventional star product "paclitaxel coated chocolate balloon" was certified by the US Food and Drug Administration (FDA) last week, and the imported products of its neurointerventional business have achieved localized production
in 2022.
In addition, the company's cardiac interventional products have also made breakthroughs: In May this year, the "intravascular shockwave series products" jointly introduced by HealthFit and Shockwave Medical, a listed company in the United States, were approved for marketing by the National Medical Products Administration (NMPA), which is the first approved type of medical device
in China.
Subsequent these products, as well as surgical products such as sutures, trousers, and full-angle laparoscopic hand-controlled robotic arms, will be produced and iteratively developed
at the Wuxi base.